-
A series of 27 lawsuits aimed at organizations controlling about 250 nonprofit hospitals in 15 states and the Chicago-based American Hospital Association (AHA) have shone the spotlight on the Emergency Medical Treatment and Labor Act (EMTALA) and its requirements concerning the treatment and admission of uninsured and underinsured patients.
-
There was a long history of frustration over lab specimen turnaround time but not anymore. Thanks to a successful Six Sigma initiative, turnaround time for the EDs criteria draws (draws based on specific patient criteria that indicate lab work will be needed) has dropped from about 46 minutes to 16 minutes.
-
A large number of emergency medicine observers agree that the inability to fully staff ED call panels has reached a critical point.
Why has the problem become so serious?
-
If youre having difficulty staffing your call panel, there are two options: You can institute a new approach internally, or contract with a company such as Emergency and Acute Care Medical Corp. (EA) in Rancho Santa Fe, CA, a management services organization with an independently contracted medical group providing call panel and stipend solutions and programs.
-
The annual impact of influenza on the United States is staggering: 10% to 20% of the population will get the flu. Some 36,000 people will die, and 114,000 will be hospitalized.
-
Despite calls for aggressive action by some epidemiologists, new draft federal guidelines on multidrug-resistant organisms (MDROs) argue against adoption of the most comprehensive methods as the sole approach to this problem.
-
The system often is blamed when pharmacists fill prescriptions incorrectly. For example, pharmacists may say they were distracted by a busy workplace, resulting in the misfilling of the orders. A new report, however, says some pharmacists are predisposed to medical errors due to individual factors, such as a lack of working memory.
-
Decision tool available on tablet splitting; Severe sufferers prefer brand name meds; Study: Medicare drug plan is confusing to elderly; Applications available for safety award.
-
Guilford Pharmaceuticals has initiated a Phase III clinical development program for Aquavan injection, a novel sedative/hypnotic that is a proprietary water-soluble prodrug of propofol.
-
Iron sucrose injection (Venofer); Sodium ferric gluconate complex (Ferrlecit),referred to as iron gluconate, and Iron dextran (DexFerrum/Infed).
